Professor Chengzhong (Michael) YU and his team are developing new nano ships that can dramatically increase the effectiveness of immunotherapy when treating three times breast cancer (TNBC). TNBC is aggressive, fast growing and accounts for 30 % of all breast cancer deaths in Australia, despite only 10-15 % of new cases.

“Despite the promise of immunotherapy, the use of the Immune system (ICIS) as a possible treatment option for TNBC is very limited,” Professor Yu said. “This means treatments that may help treat melanoma, does not work with TNBC.

ALESED 3 million researcher grants (in NHMRC (NHMCs. TNBC cancer cells and important immune responses to the attacks and to overcome the TNBC cells. To start a clinical translation in the treatment of serious cancers.

In nanotechnology and nanomedicine, including the innovation of nanoporous, which is nanoparticles and nanoparings and a drug city.The project combines elements of Professor Yu’s 20-year career in nanotechnology and nanomedicine, including nanoparticle innovation, understanding the nanoparticle-cell interaction, and drug delivery to provide new solutions for cancer treatment.

Sources

https://www.uq.edu.au/news/node/136960

https://ddnews.gov.in/en/nanotechnology-breakthrough-may-boost-treatment-for-aggressive-breast-cancer-study/